Latest News:
December 2011
Fujirebio Diagnostics, Inc. Named the #6 Best Place to Work in PA 2011
Fujirebio Diagnostics, Inc. has been named one of the Best Places to Work in PA for 2011. The “Best Places” program is a public/private partnership between Team Pennsylvania Foundation, the Pennsylvania Department of Community and Economic Development, the Pennsylvania State Council of the Society for Human Resource Management, and the Central Penn Business Journal.
This survey and awards program was designed to identify, recognize and honor the best places to be employed in Pennsylvania, benefiting the state's economy, its workforce and businesses.
September 6, 2011
Press Release: FDA Clears Next-Generation Biomarker Test to Determine Likelihood of Ovarian Cancer in Women Who Present With Adnexal Mass
Fujirebio Diagnostics, the industry leader in oncology biomarker assays, announced today that it has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) to market the company’s HE4 Test in an algorithm called ROMA™ (HE4 EIA + ARCHITECT CA 125 IITM)* to aid in assessing whether a premenopausal or postmenopausal woman who presents with an ovarian adnexal mass is at high or low likelihood of finding malignancy on surgery.
May 31, 2011
Press Release: Fujirebio
Diagnostics, Inc. Receives FDA 510 (k) Clearance for First Biomarker to Monitor Lung Cancer
Fujirebio Diagnostics, Inc., today announced that the U.S. Food and Drug Administration (FDA) has granted 510 (k) clearance to the CYFRA 21-1™ EIA assay to monitor disease progression during the course of disease and treatment of lung cancer patients. This is the first biomarker assay kit to be cleared by FDA for use in the management of patients with lung cancer.
July 20, 2010
Press Release: Fujirebio to acquire Innogenetics from Abbott
Fujirebio, a Miraca Holdings group company, announced today a definitive agreement with Abbott, the global healthcare company, to acquire all of the issued and outstanding shares of Innogenetics, a multi-national company that develops and markets a wide range of specialty diagnostics in the fields of infectious diseases, genetic testing, transplantation as well as neuro-degeneration.
Upcoming Events:
Friday, January 27, 2012
Twenty-sixth Annual Sanford H. Cole, M.D., Memorial Ob/Gyn Symposium,
Miami, FL, USA
January 26 – 29, 2012
GOG 84th Semi-Annual Meeting, San Diego, CA, USA
http://www.gog.org
February 9 – 11, 2012
SGO’s 17th Annual Winter Meeting, Olympic Valley, CA, USA
http://www.sgo.org